---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-009897"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:00:40.409444+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Nutex Health Q1 net loss $5.1M; revenue falls 29% YoY to $56.3M

## Summary
- Net loss attributable to Nutex Health of $5.1M ($0.01 EPS) vs net income of $21.4M ($0.04 EPS) in Q1 2022.
- Net revenue $56.3M, down 29% from $79.1M; hospital division revenue $49.3M vs $79.1M; population health contributed $7.0M.
- Adjusted EBITDA $2.4M; cash from operations $1.1M; cash and equivalents $32.8M at March 31.
- Closed three unprofitable Texas facilities in Q1; expects to open 4-5 micro hospitals in 2023 and 14 by end 2025.
- Entered $100M prepaid advance with Yorkville (received $12.6M net in April); $100M Lincoln Park Capital commitment unused.

## SEC filing metadata
- accession: 0001558370-23-009897
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000155837023009897/0001558370-23-009897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000155837023009897/nutx-20230515x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-009897
- JSON: https://secwatch.observer/filing/0001558370-23-009897.json
- Plain text: https://secwatch.observer/filing/0001558370-23-009897.txt

## Key facts
- Earnings Releases
  Nutex Health Inc. reported first quarter 2023 results: revenue $56.3 million, net income Net loss attributable to Nutex Health of $5.1 million.
  - Period: first quarter 2023
  - Revenue: $56.3 million
  - Net income: Net loss attributable to Nutex Health of $5.1 million
  - Result: reported results
  source text: Financial Highlights for the Three Months Ended March 31, 2023: ● Net revenue of $56.3 million. ● Net loss attributable to Nutex Health of $5.1 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837023009897/0001558370-23-009897-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.